Contact
Please use this form to send email to PR contact of this press release:
Science Financier Jeffrey Epstein Heralds FDA's Approval of Inhibitor Cocktails for Melanoma
TO:
Jeffrey Epstein
Jeffrey Epstein VI Foundation
(917) 573-7604